Skip to main content

Advertisement

SpringerLink
Log in

Maternal Hypertension and Mortality in Small for Gestational Age 22- to 29-Week Infants

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Infants born before 30 weeks gestational age (GA) to mothers with hypertension (HTN) experience lower rates of mortality and serious morbidities when corrected for maternal and infant characteristics. Growth restriction and maternal HTN are often associated. We sought to determine if small for gestational age (SGA) infants have similarly decreased mortality risk when born to mothers with HTN. We identified 6897 singleton SGA, 22 + 0 to 29 + 6 weeks GA infants born between 2008 and 2011, cared for at 578 North American centers in the Vermont Oxford Network. Chromosomal abnormalities and birth defects were excluded. Mortality rates prior to discharge were compared between 4317 HTN and 2580 comparison infants. Logistic regression was used to adjust for birth weight, infant sex, maternal race, inborn/outborn, antenatal steroid exposure, prenatal care, and GA. Small for gestational age HTN infants were older (mean: 26.9 [1.9] vs 26.6 [2.2] weeks; P<.001) and larger (HTN = 584 [159] g vs 562 [156] g; P <.001) than comparison infants. Death prior to discharge occurred in 29% of HTN and 43% of comparison infants. Univariate analyses revealed lower mortality for HTN infants (odds ratio [OR] = 0.54, 95% confidence interval [C1]: 0.48-0.60). After adjustment, mortality remained lower when compared to non-HTN infants (OR = 0.60, 95% C1: 0.52-0.69). Extremely preterm SGA infants face high rates of mortality. Although maternal HTN is associated with SGA, SGA infants born to mothers with HTN have decreased risk of mortality compared to non-HTN SGA infants, prior to and after adjustment for antenatal and maternal characteristics. This may reflect detrimental physiologic effects associated with alternative mechanisms for fetal growth restriction and is important for parental counseling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol. 2000;182(1 pt l):198–206.

    Article  CAS  PubMed  Google Scholar 

  2. Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28(1):67–80.

    Article  PubMed  Google Scholar 

  3. Ott WJ. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol. 1993;168(6 pt 1):1710–1715. discussion 5-7.

    Article  CAS  PubMed  Google Scholar 

  4. Ghidini A. Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet Gynecol Surv. 1996;51(6):376–382.

    Article  CAS  PubMed  Google Scholar 

  5. Matthews TJ, MacDorman MF, Thoma ME. Infant Mortality Statistics From the 2013 Period Linked Birth/Infant Death Data Set. Natl Vital Stat Rep. 2015;64(9):1–30.

    CAS  PubMed  Google Scholar 

  6. Chiswick ML. Intrauterine growth retardation. Br Med J (ClinRes Ed). 1985;291(6499):845–848.

    Article  CAS  Google Scholar 

  7. Kristensen S, Salihu HM, Keith LG, Kirby RS, Fowler KB, Pass MA. SGA subtypes and mortality risk among singleton births. Early Hum Dev. 2007;83(2):99–105.

    Article  PubMed  Google Scholar 

  8. Weiler J, Tong S, Palmer KR. Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study. PLoS One. 2011;6(10):e26937.

    Google Scholar 

  9. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–955.

    CAS  PubMed  Google Scholar 

  10. Jain L. Effect of pregnancy-induced and chronic hypertension on pregnancy outcome. J Perinatol. 1997;17(6):425–427.

    CAS  PubMed  Google Scholar 

  11. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391–403.

    Article  PubMed  Google Scholar 

  12. McBride CA, Bernstein IM, Badger GJ, Horbar JD, Soil RF. The effect of maternal hypertension on mortality in infants 22, 29 weeks gestation. Pregnancy Hypertens. 2015;5(4):362–366.

    Article  PubMed  Google Scholar 

  13. The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project. Pediatrics. 1993;91(3):540–545.

    Article  Google Scholar 

  14. Vermont Oxford Network: Manual of Operations: Release 12.0. Burlington: Vermont Oxford Network; 2007.

  15. Horbar JD. The Vermont-Oxford Neonatal Network: integrating research and clinical practice to improve the quality of medical care. Semin Perinatol. 1995;19(2):124–131.

    Article  CAS  PubMed  Google Scholar 

  16. Horbar JD, Leahy KA. An assessment of data quality in the Vermont-Oxford Trials Network database. Control Clin Trials. 1995;16(1):51–61.

    Article  CAS  PubMed  Google Scholar 

  17. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics—2003. Pediatrics. 2005;115(3):619–634.

    Article  PubMed  Google Scholar 

  18. Tyson JE, Younes N, Verier J, Wright LL. Viability, morbidity, and resource use among newborns of 501- to 800-g birth weight. National institute of child health and human development neonatal research network. JAMA. 1996;276(20):1645–1651.

    Article  CAS  PubMed  Google Scholar 

  19. Vohr BR, Wright LL, Dusick AM, et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics. 2004;113(4):781–789.

    Article  PubMed  Google Scholar 

  20. Zeitlin J, El Ayoubi M, Jarreau PH, et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr. 2010;157(5):733–739.el.

    Article  PubMed  Google Scholar 

  21. Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstetr Gynecol. 2004;191(2):481–487.

    Article  Google Scholar 

  22. Chen XK, Wen SW, Smith G, Yang Q, Walker M. Pregnancy-induced hypertension is associated with lower infant mortality in preterm singletons. BJOG. 2006;113(5):544–551.

    Article  CAS  PubMed  Google Scholar 

  23. McCowan LM, Roberts CT, Dekker GA, et al. Risk factors for small-for-gestational-age infants by customised birthweight cen-tiles: data from an international prospective cohort study. BJOG. 2010;117(13):1599–1607.

    Article  CAS  PubMed  Google Scholar 

  24. Bernstein IM, Meyer MC, Capeless EL. “Fetal growth charts”: comparison of cross-sectional ultrasound examinations with birth weight. J Matern Fetal Med. 1994;3(4):182–186.

    Article  Google Scholar 

  25. Bernstein IM, Mohs G, Rucquoi M, Badger GJ. Case for hybrid “fetal growth curves”: a population-based estimation of normal fetal size across gestational age. J Matern Fetal Med. 1996;5(3):124–127.

    CAS  PubMed  Google Scholar 

  26. Fry AG, Bernstein IM, Badger GJ. Comparison of fetal growth estimates based on birth weight and ultrasound references. J Matern Fetal Neonatal Med. 2002;12(4):247–252.

    Article  CAS  PubMed  Google Scholar 

  27. Zaw W, Gagnon R, da Silva O. The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics. 2003;111(6 pt 1):1273–1277.

    Article  PubMed  Google Scholar 

  28. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol. 2001;184(5):946–953.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, Larner College of Medicine, University of Vermont, 89 Beaumont Avenue, Burlington, VT, 05405, USA

    Carole A. McBride PhD & Ira M. Bernstein MD

  2. Department of Medical Biostatistics, University of Vermont, Burlington, VT, USA

    Gary J. Badger MS

  3. Vermont Oxford Network, Burlington, VT, USA

    Roger F. Soil MD

  4. Department of Pediatrics, Larner College of Medicine, University of Vermont, Burlington, VT, USA

    Roger F. Soil MD

Authors
  1. Carole A. McBride PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ira M. Bernstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary J. Badger MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roger F. Soil MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carole A. McBride PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McBride, C.A., Bernstein, I.M., Badger, G.J. et al. Maternal Hypertension and Mortality in Small for Gestational Age 22- to 29-Week Infants. Reprod. Sci. 25, 276–280 (2018). https://doi.org/10.1177/1933719117711260

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719117711260

Keywords

Search

Navigation